ATOSSA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.17
-2.69%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-4.4%
3 months
+0.0%
6 months
-59.3%
1 year
-83.6%
Year to date
-75.5%
52-week range
$1.75 – $13.57
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$21.7M
P/E
-0.6
P/B
0.8
P/S
—
Revenue
$0
Net income
-$37.71M
Diluted EPS
-4.45
Gross margin
—
Net margin
—
Return on equity
-103.00%
Total debt
$0
Cash
$26.2M
Free cash flow
-$35.78M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$8.49M | — | — | -$9.64M |
| Mar 31, 2026 | $0 | -$9.59M | — | — | -$9.58M |
| Dec 31, 2025 | $0 | -$10.94M | — | — | -$10.55M |
| Sep 30, 2025 | $0 | -$8.69M | — | — | -$6.01M |
| Jun 30, 2025 | $0 | -$8.42M | — | — | -$7.26M |
| Mar 31, 2025 | $0 | -$6.72M | — | — | -$5.97M |
| Dec 31, 2024 | $0 | -$6.35M | — | — | -$7.05M |
| Sep 30, 2024 | $0 | -$7.23M | — | — | -$4.76M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ATOS news
All market newsNo ticker-linked stories are in the current archive.